Physician

J Michael Jumper, M.D.

According to 2025 Medicare claims, J. Jumper, M.D. (NPI: 1609844687) practices ophthalmology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Contra Costa, CA. This provider's primary affiliated billing organization is WEST COAST RETINA MEDICAL GROUP, INC. (NPI: 1053389064; TIN: 942275625) and primary practice location at 94596-3827.

Jumper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,265 traditional Medicare patients, billed 34,295 HCPCS/CPT codes, and received $2,985,529 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 525 prescription claims across 184 beneficiaries totaling $25,466 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 16 records totaling $28,843. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,121,639 to $2,985,529. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $36,627 and ending at $25,466. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $2,121,639 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,274,761 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,245,571 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,737,838 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,810,473 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,980,768 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,427,316 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,505,252 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,713,740 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,985,529 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0989,734$2,121,639
20161,15911,001$2,274,761
20171,10710,677$2,245,571
20181,18410,884$1,737,838
20191,23611,076$1,810,473
20201,06410,422$1,980,768
20211,16312,365$2,427,316
20221,23813,891$2,505,252
20231,21624,211$2,713,740
20241,26534,295$2,985,529

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$41K2015 Drug cost: $36,627 (USD; Tot_Drug_Cst)2016 Drug cost: $27,470 (USD; Tot_Drug_Cst)2017 Drug cost: $36,199 (USD; Tot_Drug_Cst)2018 Drug cost: $33,690 (USD; Tot_Drug_Cst)2019 Drug cost: $41,409 (USD; Tot_Drug_Cst)2020 Drug cost: $41,217 (USD; Tot_Drug_Cst)2021 Drug cost: $38,733 (USD; Tot_Drug_Cst)2022 Drug cost: $29,000 (USD; Tot_Drug_Cst)2023 Drug cost: $25,691 (USD; Tot_Drug_Cst)2024 Drug cost: $25,466 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015138534$36,627
2016151466$27,470
2017123382$36,199
2018142449$33,690
2019160503$41,409
2020128368$41,217
2021140402$38,733
2022157393$29,000
2023154393$25,691
2024184525$25,466

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2002,094$659
67028Injection of drug into eye3651,581$126
92014Established patient complete exam of visual system9111,245$120
92012Established patient problem focused exam of visual system342706$87
92134Imaging of retina1,2082,858$40

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1287,845$6,721
DifluprednateDifluprednate38856$3,595
Brimonidine TartrateBrimonidine Tartrate241,243$826
Timolol MaleateTimolol Maleate382,354$786
Ketorolac TromethamineKetorolac Tromethamine20860$639

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$262Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.11$28,581Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for J. Michael Jumper, M.D.?

Tedicare shows public-source Medicare data for J. Michael Jumper, M.D. (NPI 1609844687), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does J. Michael Jumper, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to J. Michael Jumper, M.D.?

J. Michael Jumper, M.D. is linked to WEST COAST RETINA MEDICAL GROUP, INC. (billing NPI 1053389064) in the available physician profile data.

Does J. Michael Jumper, M.D. have Open Payments data?

J. Michael Jumper, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.